RLYP News 22.83 Relypsa Inc (RLYP)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Relypsa Inc (RLYP) 22.83 $RLYP

Relypsa, Inc. Announces Closing of Public Offering of Common Stock
GlobeNewswire - Wed Apr 16, 3:00PM CDT
Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced the closing of its public offering of 4,130,611 shares of its common stock at a price to the public of $24.50 per share for gross proceeds of approximately $101 million, which includes the exercise in full by the underwriters of their option to purchase up to 538,775 additional shares of common stock. Relypsa estimates net proceeds from the offering to be approximately $94 million, after deducting underwriting discounts and commissions and estimated offering expenses.

Nasdaq stocks posting largest percentage decreases
AP - Tue Apr 15, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:

Relypsa, Inc. Announces Pricing of Public Offering of Common Stock
GlobeNewswire - Thu Apr 10, 10:50PM CDT
Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced the pricing of an underwritten public offering of 3,591,836 shares of its common stock at a price to the public of $24.50 per share for gross proceeds of approximately $88 million. Relypsa estimates net proceeds from the offering to be approximately $82 million, after deducting underwriting discounts and commissions and estimated offering expenses. In addition, Relypsa has granted the underwriters a 30-day option to purchase up to an additional 538,775 shares of common stock.

Relypsa, Inc. Announces Proposed Public Offering of Common Stock
GlobeNewswire - Tue Apr 08, 3:05PM CDT
Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced it has commenced an underwritten public offering of shares of its common stock to raise aggregate proceeds of $80 million. All of the shares of the common stock to be sold in the offering will be offered by Relypsa. In addition, Relypsa intends to grant the underwriters a 30-day option to purchase up to an additional 15 percent of the number of shares sold. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Relypsa Names Sylvia R. Wheeler V.P. Investor Relations and Corporate Affairs
GlobeNewswire - Wed Apr 02, 8:43AM CDT
Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced the appointment of Sylvia R. Wheeler to the position of Vice President, Investor Relations and Corporate Affairs. Ms. Wheeler, a veteran biopharmaceutical executive, joins Relypsa with over 20 years of experience in investor relations and corporate communications. In her new role, Ms. Wheeler will be a member of the leadership team and will report to John Orwin, President and Chief Executive Officer of Relypsa.

Weakness Seen in Relypsa (RLYP): Stock Plunges 19.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 27, 7:42AM CDT
Relypsa (RLYP) fell over 19% in the last trading session amid high volumes, breaking its recent volatile trend as it is currently trading below the volatile price range of last one month.

Relypsa (RLYP) in Focus: Stock Adds 12.4% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 26, 8:46AM CDT
Relypsa was a big mover last session, with shares rising over 12% on the day.

Rev Shark: A Messy Day of Action
at The Street - Wed Mar 19, 3:31PM CDT
A few minor changes to Fed policy were enough to spook the market.

Narrower-Than-Expected Loss at Relypsa - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 18, 8:20AM CDT
Relypsa reported a loss of 68 cents per share narrower than the Zacks Consensus Estimate of a loss of 74 cents.

Relypsa Announces Fourth Quarter and Full Year 2013 Financial Results
GlobeNewswire - Mon Mar 17, 3:26PM CDT
Relypsa, Inc. (Nasdaq: RLYP), a biopharmaceutical company, today reported financial results for the fourth quarter and year ended December 31, 2013.

Relypsa to Present at Two Upcoming Investor Conferences in March
GlobeNewswire - Wed Feb 26, 8:22AM CST
Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced that John Orwin, Chief Executive Officer, will present a corporate overview of the company at the Cowen & Co. 34th Annual Health Care Conference in Boston, MA on March 4 at 10:40 am ET and at the 26th Annual ROTH Conference in Dana Point, CA on March 10 at 5:00 pm PT.

Why Cadence Pharmaceuticals, Relypsa, and Hansen Medical Are Today's 3 Best Stocks
Sean Williams, The Motley Fool - Motley Fool - Tue Feb 11, 4:15PM CST
You could certainly say that Janet Yellen met or bested expectations in her first testimony to Congress as Federal Reserve chairwoman today, as evidenced by the broad-based rally in the S&P 500 . As my Foolish colleague Travis Hoium noted...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 185

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 198

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
Domino's Probe Puts Franchise Disclosure Under Lens

Updated Category News Views 139

A franchisee's shuttered stores can turn cheerful unit-growth talk into a nasty accounting of credibility, and that is the uncomfortable territory Domino's now occupies. Kahn Swick & Foti has opened an investigation into whether Domino's officers and directors breached fiduciary duties or violated state or federal law. That is not a finding of misconduct. It is a legal...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 136

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 112

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 184

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 158

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 149

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 0

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 138

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading

Top 5 Most Recently Viewed Articles

Analysts Raise Price Targets for Agilent After Strong Earnings

Updated Category News Views 139

Agilent Technologies Inc Reports Impressive Fourth Quarter Results Agilent Technologies Inc (NYSE: A) celebrated a positive earnings surprise for its latest quarterly results, significantly surpassing forecasts and setting a promising tone for the year ahead. The company's earnings per share reached $1.59, edging out analyst expectations, which were set at $1.58 per...

Continue Reading
AstraZeneca's Historic NYSE Move Signals Market Shift

Updated Category News Views 53

AstraZeneca's Gigantic Leap In the hustle of Wall Street's whirring machine, June 5, 2026, dawned with a palpable buzz. Why? AstraZeneca (NYSE:AZN) just pulled off the biggest market cap transfer in the New York Stock Exchange's epic 234-year saga. Now that's a splash, not just a ripple. It’s like watching a giant whale breach in an already crowded ocean. But what does...

Continue Reading
Doughlicious Brings Irresistible Frozen Treats to Target Stores

Updated Category News Views 247

Doughlicious Expands Offerings into Target Stores Doughlicious, the celebrated brand born in London, is making waves across the United States as it announces its expansion into Target stores nationwide. Building on their successful U.S. launch at Whole Foods Market, the brand is excited to bring its crave-worthy frozen cookie dough and gelato bites to an even broader...

Continue Reading
Amber Grid Seeks New CEO: Selection Process Announced

Updated Category News Views 246

Amber Grid CEO Selection Process Initiated AB Amber Grid, with the legal entity code: 303090867, is located at Laisv?s ave. 10, LT-04215 Vilnius, Lithuania. As the current CEO's five-year tenure approaches its conclusion, the Board has officially announced the commencement of the selection process for the next CEO. Application Timeline and Processes Interested candidates...

Continue Reading
Vishay Precision Group Reports Third Quarter Results for FY24

Updated Category News Views 117

Vishay Precision Group Announces Q3 2024 Financial Results Vishay Precision Group, Inc. (NYSE: VPG), a recognized leader in precision measurement and sensing technologies, recently released its financial results for the third quarter of fiscal 2024, closing on September 28, 2024. The report highlights various metrics that provide insight into the company’s performance...

Continue Reading